Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Hypertension affects ~23% of Canadian adults.1
Modest blood pressure reduction can reduce the risk of cardiovascular events.3,4
Fewer hypertension patients are achieving control, while cardiovascular events continue to be the leading cause of death in the U.S..2
Developing a successful hypertension program allows you to build focus and multidisciplinary expertise to optimize patient care.5
Getting a program up and running may seem like a lot of work. We’ve gathered the resources you need to get started.
Understand how to improve blood pressure control rates through this evidence-based quality improvement program.
See the benefits and details of becoming an AHA-certified hypertension center.
This package presents a list of process improvements that outpatient clinical settings can implement as they work toward hypertension control. Examples resulted in 80% control rates.
Explore a toolkit from the CDC Division for Heart Disease and Stroke Prevention with information and resources for implementing the HMP and improving hypertension control.
The more patients understand about hypertension, the more they will take control of their condition. Here are tools and resources you can use to help educate them.
Developed by Hypertension Canada, these patient resources make it easier to help patients understand the prevalence and serious health risks of hypertension.
VISIT HYPERTENSION CANADA
Inspired by the Surgeon General’s Call to Action, the CDC created a toolkit with social media content, a PowerPoint presentation, and other materials to help spread the word about why it is so important to get hypertension under control.
See how much you know about the prevalence and risks of uncontrolled hypertension.
Epidemiology of Resistant Hypertension in Canada
Alexander A. Leung et al.
Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women Between 2007 and 2017
Alexander A. Leung et al.
Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387:957–67.
Rahimi K, Bidel Z, Nazarzadeh M, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. The Lancet. 2021 397; 1625–36.
Casey DE Jr, Daniel DM, Bhatt J, Carey RM, Commodore-Mensah Y, Holmes A, Smith AP, Wozniak G, Wright JT Jr. Controlling High Blood Pressure: An Evidence-Based Blueprint for Change. Am J Med Qual. 2021 May 20. doi: 10.1097/01.JMQ.0000749856.90491.43. Epub ahead of print. PMID: 34038915.